« Back
Home /
Entinostat (MS-275)

Entinostat (MS-275)

Item no.	M1791-50mg
Manufacturer	AbMole
CASRN	209783-80-2
Amount	50mg
Category	Oncology Neuroscience Aging & Neurological Disorders Neural Epigenetics Inhibitors & Compound Libraries Small Molecules By Organ Breast Cancer
Type	Inhibitors
Specific against	other
Purity	0,9936
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	SNDX-275, MS-27-275
Similar products	MS-275, Entinostat, SNDX-275, MS-27-275
Available
Target Information	HDAC
Molecular Weight	376, 4
Solubility	DMSO 40 mg/mL
Bioactivity information	Entinostat (MS-275) is an oral and selective class I HDAC inhibitor, with IC50s of 243 nM, 453 nM, and 248 nM for HDAC1, HDAC2, and HDAC3, respectively.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1791-50mg-safety-datasheet.pdf